Bulletin of Stomatology and Maxillofacial Surgery
ISSN 1829-006X
2025; 297–304
Shared with The Gufo

SYNERGISTIC INTERACTIONS BETWEEN STREPTOCOCCUS MUTANS AND CANDIDA ALBICANS IN ORAL BIOFILMS AND ITS THERAPEUTIC IMPLICATIONS IN DENTAL CARIES: A NARRATIVE REVIEW

Received: 2026-04-08 · Published: 2025-10-14

Shared article.
Original title
SYNERGISTIC INTERACTIONS BETWEEN STREPTOCOCCUS MUTANS AND CANDIDA ALBICANS IN ORAL BIOFILMS AND ITS THERAPEUTIC IMPLICATIONS IN DENTAL CARIES: A NARRATIVE REVIEW
Author
Mangala Sajjanar
Source journal
Bulletin of Stomatology and Maxillofacial Surgery
Published
2025-10-14
Licence
Creative Commons Attribution-NonCommercial 4.0 International
Original
https://doi.org/10.58240/1829006X-2025.21.9-297

Abstract

Background: Dental caries is a chronic, multifactorial disease resulting from microbial dysbiosis within the oral biofilm. The persistent colonization and cooperative behavior of specific microbial species contribute significantly to its pathogene. Objective: This review explores the synergistic interactions between Streptococcus mutans and Candida albicans, two prominent oral microorganisms, with a focus on their molecular crosstalk, clinical relevance, and implications for targeted therapy. Materials and Methods: A narrative synthesis was conducted based on peer-reviewed literature examining the co- pathogenic mechanisms, biofilm dynamics, and emerging anti-biofilm strategies targeting dual-species communities. Results: Current evidence demonstrates that C. albicans enhances extracellular polysaccharide production by S. mutans through glucosyltransferase activity, promotes glucan-mediated co-adhesion, and modulates virulence gene expression in both organisms. Their co-existence leads to increased biofilm biomass, acidogenic potential, and resilience against conventional antimicrobial measures. These interactions are notably prevalent in early childhood caries and immunocompromised hosts. Conclusion: The cross-kingdom synergism between S. mutans and C. albicans constitutes a potent pathogenic axis in cariogenesis. Targeted disruption of this alliance through novel therapeutic strategies—such as glucosyltransferase inhibitors, nanoparticle-based antimicrobials, and biofilm-disrupting agents—holds potential for improving caries management, particularly in high-risk populations. Further clinical validation is necessary to translate these findings into effective, personalized interventions.
1 / ? 100% Open in new tab Download Cite

Loading the full text…

Download Follow Updates